Armistice Capital Reports 4.99% Stake in Curis, Inc.

2026-05-15SEC Filing SCHEDULE 13G/A (0001172661-26-002137)

Armistice Capital, LLC and its managing member Steven Boyd have filed a Schedule 13G/A amendment reporting a 4.99% ownership stake in Curis, Inc. (CRIS). The filing discloses ownership of 679,033 shares of common stock as of March 31, 2026, representing a new position for the investment firm. Armistice Capital serves as the investment manager for Armistice Capital Master Fund Ltd., which directly holds the shares. The firm exercises shared voting and dispositive power over the securities through its investment management agreement. Both Armistice Capital and Steven Boyd report shared voting and dispositive power over the entire position, with no sole power. The filing indicates this is a passive investment not intended to influence control of the company, and the ownership percentage is intentionally kept below the 5% threshold that would trigger additional reporting requirements.

Ticker mentioned:CRISInstitution mentioned:ARMISTICE CAPITAL, LLC
Related industry:Biotechnology